Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra;Erfolgreiche behandlung der klinischen manifestationen des Muckle-Wells-syndroms mit anakinra

Deutsche Medizinische Wochenschrift

Volumn 131, Issue 34-35, 2006, Pages 1863-1866

  Dybowski, F ^a   Jakobs, B ^a   Altmeyer, P ^b   Braun, Jürgen ^a  

^a RHEUMAZENTRUM RUHRGEBIET   (Germany)

^b ST JOSEF HOSPITAL   (Germany)

Author keywords

Interleukin 1 receptor antagonist; Muckle wells syndrome; Periodic fever syndromes

Indexed keywords

RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; ANTIRHEUMATIC AGENT; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SIALOGLYCOPROTEIN;

ADULT; ANAMNESIS; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; FEVER; GENETIC DISORDER; HEARING IMPAIRMENT; HUMAN; MUCKLE WELLS SYNDROME; TREATMENT OUTCOME; URTICARIA; VISUAL IMPAIRMENT; ACUTE PHASE RESPONSE; ADOLESCENT; CONJUNCTIVITIS; DRUG ANTAGONISM; FAMILIAL AMYLOIDOSIS; FATIGUE; GENETICS; HEARING LOSS; IMMUNOLOGY; KIDNEY DISEASE; MIDDLE AGED; MUTATION; PEDIGREE; SYNDROME; VISUAL DISORDER;

ACUTE-PHASE REACTION; ADOLESCENT; AMYLOIDOSIS, FAMILIAL; ANTIRHEUMATIC AGENTS; ARTHRALGIA; CONJUNCTIVITIS; FATIGUE; FEMALE; HEARING LOSS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KIDNEY DISEASES; MIDDLE AGED; MUTATION; PEDIGREE; RECEPTORS, INTERLEUKIN-1; SIALOGLYCOPROTEINS; SYNDROME; TREATMENT OUTCOME; URTICARIA; VISION, LOW;

EID: 33749165103     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-949170     Document Type: Article

References (15)

1. Alexander T, Klotz O et al. Successful treatment of acute visual loss in Muckle Wells syndrome with interleukin 1 receptor antagonist. Ann Rheum Dis 2005; 64: 1245-1246
2. Bodar EJ et al. Effekt of Etanercept and Anakinra on inflammatory attacks in the hyperIgD syndrome. J Medicine 2005; 43: 260-264
3. Braun J et al. Therapy of ankylosing spondylitis Part II. Scan J Rheum 2005; 34: 178-190
4. Cuisset L, Drenth JP et al. Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet 1999; 65: 1054-1059
5. Fitzgerald AA, LeClercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to Anakinra in patients with refractory adult-onset Still's Disease. Arthritis Rheum 2005; 52: 1794-1803
6. Granel B, Serratrice J, Disdier P, Weiller P-J. Dramatic improvement with anakinra in a case of chronic infantile neurological cutaneous and articular (CINCA) syndrome. Rheumatology 2005; 44: 689-690
7. Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Spectrum of clinical features in the Muckle-Wells Syndrome and response to Anakinra. Arthritis Rheum 2005; 50: 607-612
8. Hawkins PN, Lachmann HJ. Interleukin 1-Receptor Antagonist in the Muckle - Wells Syndrome. N Eng J Med 2003; 25: 2583-2584
9. Lamprechr P, Moosig F et al. Small vessel vasculitis and relapsing panniculitis in tumor necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 2004; 63: 1518-1520
10. McDermott MF, Aganna E, Hitman GA, Ogunkolade BW, Booth DR, Hawkins PN. An autosomal dominant periodic fever associated with AA amyloidosis in a north indian family maps to distal chromosome 1q. Arthritis Rheum 2000; 43: 2034-2040
11. Ramos E, Arosregui JI et al. Positive clinical and biochemical responses to anakinra in a 3-yr-old patient with cryopyrin-associated periodic syndrome (CAPS). Rheumatology 2005; 44: 1072-1073
12. Rose CD, Doyle TM, McIlvain Simpson G et al. Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 2005; 32: 373-375
13. Samuel J, Ozen S. Familial Mediterranean fever and the other autoinflamatory syndromes: evaluation of the patient with recurrent fever. Cur Opin Rheumatol 2006; 18: 108-117
14. Tunca M, Ozdogan H. Molecular and genetic characteristics of hereditary autoinflammatory diseases. Curr Drug Targets Inflamm Allergy 2005; 4: 77-80
15. Waugh J, Perry C. Anakinra a review of its use in the management of rheumatoid arthritis. BioDrugs 2005; 19: 189-203